首頁 > 市場調查報告書 > 食物/飲料

機能性食品

眼部保健品市場規模、佔有率和成長分析（按成分類型、適應症、劑型、分銷管道和地區分類）：產業預測（2026-2033 年）

市場調查報告書

商品編碼

1896861

眼部保健品市場規模、佔有率和成長分析（按成分類型、適應症、劑型、分銷管道和地區分類）：產業預測（2026-2033 年）

Eye Health Supplements Market Size, Share, and Growth Analysis, By Ingredient Type, By Indication (Age-related Macular Degeneration, Cataract), By Formulation, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，眼保健品市場規模將達到 26.7 億美元，到 2025 年將達到 28.5 億美元，到 2033 年將達到 47.9 億美元，在預測期（2026-2033 年）內複合年成長率為 6.7%。

眼保健品市場的主要驅動力是視力障礙和近視的日益增多，而螢幕使用時間的增加和遠端辦公趨勢進一步加劇了這個問題。眼科疾病（包括老齡化黃斑部病變、乾眼症和白內障）的增加，以及眼科醫師的建議，都在推動對這些保健品的需求。全球約有22億人受到視力障礙的影響，因此，尤其是在失明率顯著更高的低收入地區，迫切需要有效的解決方案。已開發國家的消費者在醫療產品（包括眼部保健膳食補充劑）上的支出不斷增加，進一步推動了市場成長。此外，電子商務的興起和創新眼部保健產品的推出，帶動了線上銷售的激增，滿足了數百萬人的未滿足需求，預示著市場將持續強勁成長。

眼保健品市場促進因素

老齡化黃斑部病變、白內障和乾眼症等各種眼科疾病發生率的不斷上升，顯著推動了對護眼保健品的需求。隨著世界人口老化，這些疾病的盛行率可能會進一步上升，擴大了促進和維護眼部健康的產品的市場。消費者越來越傾向選擇能夠降低這些疾病相關風險的保健品，隨著眼部保健意識的不斷提高，護眼保健品市場正處於強勁的成長期。

限制眼保健品市場的因素

由於缺乏科學證據支持眼部保健品的長期療效和安全性，該市場面臨嚴峻挑戰。儘管一些個案報告和初步研究表明其具有潛在益處，但缺乏全面的臨床試驗和一致的調查方法令人擔憂。缺乏嚴謹的科學檢驗可能會削弱消費者的信任和接受度，最終阻礙市場成長。潛在買家尋求產品功效的確認，而缺乏廣泛且有據可查的研究則構成重大阻礙因素，並可能限制眼部保健品市場的整體發展和成功。

眼保健品市場趨勢

受消費者對眼部健康重要性以及預防老齡化相關視力問題的意識不斷提高的推動，眼保健品市場正經歷顯著成長。隨著越來越多的人認知到營養支持對維持最佳眼部功能的重要性，他們也擴大將眼部保健品納入日常健康計劃。這種積極主動的態度反映了整體健康護理的更廣泛趨勢，該趨勢強調預防保健，並尋求能夠促進視力清晰度和整體眼部健康的高品質保健品。因此，對眼部健康的日益關注正在影響著該行業的產品供應和行銷策略。

參天製藥（日本）
樂敦製藥（日本）
Dompe Farmaceutici（義大利）
Vianex SA（希臘）
雅培實驗室（美國）
博士倫（美國）
愛爾康（瑞士）
輝瑞公司（美國）
諾華公司（瑞士）
Thea Pharma（法國）
Similasan AG（瑞士）
傑米森健康中心（加拿大）
Nature's Way（美國）
NOW Foods（美國）
Nature's Bounty（美國）
GNC控股（美國）
康寶萊營養品（美國）
安麗（美國）
丹麥 Pharma Nord
Solgar（美國）

結論與建議

簡介目錄

Product Code: SQMIG35I2201

Eye Health Supplements Market size was valued at USD 2.67 Billion in 2024 and is poised to grow from USD 2.85 Billion in 2025 to USD 4.79 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The market for eye health supplements is primarily driven by the increasing prevalence of vision impairment and myopia, exacerbated by heightened screen usage and remote work trends. Factors such as rising eye conditions including age-related macular degeneration, dry eye syndrome, and cataracts, alongside endorsements from ophthalmologists, are propelling demand for these supplements. With approximately 2.2 billion individuals globally affected by vision issues, particularly in low-income regions where rates of blindness are significantly higher, the need for effective solutions is critical. Consumers in developed countries exhibit high spending on healthcare products, including dietary supplements for eye health, further fueling market growth. Moreover, the surge in online sales due to e-commerce accessibility and the introduction of innovative eye health products cater to the unmet needs of millions, promising robust market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Eye Health Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Eye Health Supplements Market Segments Analysis

Global Eye Health Supplements Market is segmented by Ingredient Type, Indication, Formulation, Distribution Channel and region. Based on Ingredient Type, the market is segmented into Lutein & Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin and Others. Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, Inflammation and Others. Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, Liquid and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Hypermarkets & Supermarkets and E-Commerce. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Eye Health Supplements Market

The increasing occurrence of various eye-related conditions, including age-related macular degeneration, cataracts, and dry eye syndrome, is significantly fueling the demand for eye health supplements. With a continually aging global population, the likelihood of these disorders becoming more prevalent is rising, thereby expanding the market for products designed to promote and maintain optimal eye health. Consumers are increasingly turning to supplements that can potentially mitigate the risks associated with these conditions, leading to a robust growth trajectory in the eye health supplements sector as awareness of eye care continues to gain prominence.

Restraints in the Eye Health Supplements Market

The Eye Health Supplements market faces a significant challenge due to the insufficient scientific evidence supporting their effectiveness and safety over the long term. Despite some anecdotal reports and initial research suggesting potential benefits, the scarcity of comprehensive clinical studies and consistent research methodologies raises concerns. This gap in rigorous scientific validation may undermine consumer trust and acceptance, ultimately impeding market growth. As potential buyers seek assurance about the efficacy of these products, the absence of widespread, well-documented research can serve as a considerable restraint, limiting the overall development and success of eye health supplements in the market.

Market Trends of the Eye Health Supplements Market

The Eye Health Supplements market is experiencing a notable surge driven by increasing consumer awareness surrounding the significance of eye health and the prevention of age-related vision issues. As more individuals recognize the critical role of nutritional support for optimal eye function, they are integrating eye health supplements into their daily wellness routines. This proactive approach reflects a broader trend towards holistic health management, prompting consumers to prioritize preventive care and seek high-quality supplements that promote vision clarity and overall ocular well-being. Consequently, this heightened focus on eye health is shaping product offerings and marketing strategies within the industry.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Eye Health Supplements Market Size by Ingredient Type & CAGR (2026-2033)

Market Overview
Lutein & Zeaxanthin
Antioxidants
Omega-3 Fatty Acids
Coenzyme Q10
Flavonoids
Alpha-Lipoic Acid
Astaxanthin
Others

Global Eye Health Supplements Market Size by Indication & CAGR (2026-2033)

Market Overview
Age-related Macular Degeneration (AMD)
Cataract
Dry Eye Syndrome
Inflammation
Others

Global Eye Health Supplements Market Size by Formulation & CAGR (2026-2033)

Market Overview
Tablets
Capsules
Powder
Softgels
Liquid
Others

Global Eye Health Supplements Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacy
Retail Pharmacy
Hypermarkets & Supermarkets
E-Commerce

Global Eye Health Supplements Market Size & CAGR (2026-2033)

North America (Ingredient Type, Indication, Formulation, Distribution Channel)
- US
- Canada
Europe (Ingredient Type, Indication, Formulation, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Ingredient Type, Indication, Formulation, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Ingredient Type, Indication, Formulation, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Ingredient Type, Indication, Formulation, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Santen Pharmaceutical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rohto Pharmaceutical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dompe Farmaceutici (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vianex S.A. (Greece)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch + Lomb (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thea Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Similasan AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jamieson Wellness (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nature's Way (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NOW Foods (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nature's Bounty (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GNC Holdings (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Herbalife Nutrition (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amway (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharma Nord (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solgar (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments